(Q41120070)

27 September 2017

Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer (English)

1 reference

27 September 2017

Zhaomei Mu

1

1 reference

27 September 2017

Chun Wang

2

1 reference

27 September 2017

Zhong Ye

3

1 reference

27 September 2017

Laura Austin

4

1 reference

27 September 2017

Jesse Civan

5

1 reference

27 September 2017

Terry Hyslop

6

1 reference

27 September 2017

Juan P Palazzo

7

1 reference

27 September 2017

Rebecca Jaslow

8

1 reference

27 September 2017

Bingshan Li

9

1 reference

27 September 2017

Ronald E Myers

10

1 reference

27 September 2017

Juntao Jiang

11

1 reference

27 September 2017

Jinliang Xing

12

1 reference

27 September 2017

Hushan Yang

13

1 reference

27 September 2017

Massimo Cristofanilli

14

1 reference

27 September 2017

language of work or name

English

0 references

publication date

16 November 2015

1 reference

Breast Cancer Research and Treatment

27 September 2017

1 reference

27 September 2017

154

1 reference

27 September 2017

3

1 reference

27 September 2017

563-571

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-015-3636-4

27 September 2017

0 references

cites work

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumor cell analysis: technical and statistical considerations for application to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumor cells as a window on metastasis biology in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Inflammatory breast cancer and development of brain metastases: risk factors and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Circulating tumor cells in newly diagnosed inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3636-4

10.1007/S10549-015-3636-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference